Amaç: Çalışmamızda, benign patolojiler nedeniyle uygulanan cerrahiler sonrası meydana gelen vezikovajinal fistül (VVF) olgularında, transvezikal onarıma ait tek merkez, uzun dönem sonuçlarımızı sunmayı amaçladık. Gereç ve Yöntemler: 2005-2020 yılları arasında bilgisayar sistemimizden verilerine ulaşılabilen ve en az 6 aylık takipleri olan, transvezikal VVF onarım yapılan 49 hasta retrospektif olarak değerlendirildi. Hastaların yaşı, VVF'ye yol açan patolojisi, ek hastalığı, fistül boyutu, fistül yerleşimi ve takip süreleri kaydedildi. Transvezikal VVF onarımının ilk cerrahiden ne kadar sonra uygulandığı, komplikasyon ve nüks gelişip gelişmediği not edildi. Bulgular: Hastaların ortalama yaşı 45,4±10,3 (18-65) yıl olarak hesaplandı. Hastaların etiyolojisinde; 41'inde (%83,6) benign nedenlerde uygulanan histerektomi, 8'inde (%16,4) sezaryenin rol oynadığı görüldü. Ortalama fistül boyutu 17,6±10,4 (3-50) mm olarak hesaplandı. VVF; 46'sında (%93,8) supratrigonal, 3'ünde (%6,2) trigonal yerleşimliydi. İkisinde (%4,1) ilk yapılan cerrahi sonrası ilk 2 hafta içinde, 47'sinde (%95,9) ilk uygulanan cerrahiden ortanca 4 (3-72) ay sonra VVF onarımı yapıldığı gözlendi. Hiçbir hastada peroperatif komplikasyon gelişmedi, ancak 2'sine (%4,1) postoperatif dönemde kan transfüzyonu yapıldı. Ortalama 79,34±48,05 (8-172) aylık takiplerde, 47'sinde (%95,9) VVF'nin iyileştiği, 2'sinde (%4,1) nüks meydana geldiği saptandı. Nüks gelişimi ve peroperatif sistostomi yerleştirilmesi açısından istatistiksel anlamlı farklılık gözlenmedi (p=0,544). Yine çalışma kapsamında 3'ünde (%6,12) diabetes mellitus saptanmış olup, bu hastaların birinde (%2,04) nüks meydana geldi. Nüks gelişen her 2 hastanın da histerektomi öyküsü olduğu görüldü. Fistül boyutu ile nüks arasında ilişki saptanmadı (p=0,174). Sonuç: Benign nedenlerle uygulanan cerrahiler sonrası meydana gelen, vajen kafı veya mesanede supratrigonal yerleşimli VVF vakalarında, transvezikal VVF onarımı öncelikli tercih edilebilir. Özellikle 15 yıla uzanan süreçte, yüksek başarı oranları ve oldukça düşük nüks oranları bu tercih sebebini desteklemektedir.
Anahtar Kelimeler: Fistül; vezikovajinal; benign patolojiler; transvezikal
Objective: In our study, we aimed to present our singlecenter, long-term results of transvesical vesicovaginal fistule (VVF) repair, occurred after surgeries due to benign pathologies. Material and Methods: Forty-nine patients who underwent transvesical VVF repair between 2005-2020, whose data were available from our database, and had at least 6 months of follow-up, were retrospectively evaluated. The age of the patients, pathology caused VVF, comorbidity, fistule size, fistule location, and follow-up periods were recorded. It was noted how long after the transvesical VVF repair was performed after the first surgery, and whether any complications or recurrence occurred. Results: The mean age of the patients was calculated as 45.4±10.3 (18-65) years. It was observed that hysterectomy performed for benign reasons in 41 (83.6%) patients, and cesarean in 8 (16.4%) patients played a role in the etiology of the patients. The mean fistula size was calculated as 17.6±10.4 (3-50) mm. VVF was supratrigonal in 46 (93.8%) patients, and trigonal in 3 (6.2%) patients. VVF repair was performed in 2 (4.1%) patients within the first 2 weeks after the first surgery, and in 47 (95.9%) patients with a median of 4 (3-72) months after the first surgery. There were no peroperative complications in any of the patients, but 2 (4.1%) patients received blood transfusion in the postoperative period. In an average of 79.34±48.05 (8-172) months of follow-up, it was found that VVF was cured in 47 (95.9%) patients, and recurrence occurred in 2 (4.1%) patients. There was no statistically significant difference in terms of recurrence and peroperative cystostomy placement (p=0.544). In the study, diabetes mellitus was found in 3 (6.12%) patients, and recurrence occurred in one (2.04%) of these patients. It was observed that both patients who had recurrence, accompanied a history of hysterectomy. There was no correlation between fistule size and recurrence (p=0.174). Conclusion: Transvesical VVF repair may be preferred primarily in VVF cases with a supratrigonal location in the bladder or vaginal cuff after surgery performed for benign reasons. High success rates, and very low recurrence rates, especially in a period of up to 15 years, support this preference.
Keywords: Fistule; vesicovaginal; benign pathologies; transvesical
- Hillary CJ, Osman NI, Hilton P, Chapple CR. The aetiology, treatment, and outcome of urogenital fistulae managed in well- and low-resourced countries: A systematic review. Eur Urol. 2016;70(3):478-92. [Crossref] [PubMed]
- Rovner ES. Urinary tract fistula. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 9th ed. Philadelphia: Saunders; 2007. p.2322-90. [Link]
- Balgobin S, Montoya TI, Shi H, Acevedo JF, Keller PW, Riegel M, et al. Estrogen alters remodeling of the vaginal wall after surgical injury in guinea pigs. Biol Reprod. 2013;89(6):138. [Crossref] [PubMed] [PMC]
- El-Azab AS, Abolella HA, Farouk M. Update on vesicovaginal fistula: A systematic review. Arab J Urol. 2019;17(1):61-8. [Crossref] [PubMed] [PMC]
- Bai SW, Huh EH, Jung DJ, Park JH, Rha KH, Kim SK, et al. Urinary tract injuries during pelvic surgery: incidence rates and predisposing factors. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(4):360-4. [Crossref] [PubMed]
- Eilber KS, Kavaler E, Rodríguez LV, Rosenblum N, Raz S. Ten-year experience with transvaginal vesicovaginal fistula repair using tissue interposition. J Urol. 2003;169(3):1033-6. [Crossref] [PubMed]
- Harris WJ. Early complications of abdominal and vaginal hysterectomy. Obstet Gynecol Surv. 1995;50(11): 795-805. [Crossref] [PubMed]
- Ostrzenski A, Ostrzenska KM. Bladder injury during laparoscopic surgery. Obstet Gynecol Surv. 1998; 53(3):175-80. [Crossref] [PubMed]
- Elkins TE. Surgery for the obstetric vesicovaginal fistula: a review of 100 operations in 82 patients. Am J Obstet Gynecol. 1994;170(4):1108-18; discussion 1118-20. [Crossref] [PubMed]
- Burkhard FC, Bosch JLHR, Cruz F, Lemack GE, Nambiar AK, Thiruchelvam N, et al. EAU Guidelines on Urinary Incontinence Appendix A: Non obstetric urinary fistula. Limited text update March 2018. [Link]
- Mondet F, Chartier-Kastler EJ, Conort P, Bitker MO, Chatelain C, Richard F. Anatomic and functional results of transperitoneal-transvesical vesicovaginal fistula repair. Urology. 2001;58(6):882-6. [Crossref] [PubMed]
- Raut V, Bhattacharya M. Vesical fistulae-an experience from a developing country. J Postgrad Med. 1993;39(1):20-1. [PubMed]
- Persky L, Herman G, Guerrier K. Nondelay in vesicovaginal fistula repair. Urology. 1979;13(3):273-5. [Crossref] [PubMed]
- Blaivas JG, Heritz DM, Romanzi LJ. Early versus late repair of vesicovaginal fistulas: vaginal and abdominal approaches. J Urol. 1995;153(4):1110-2; discussion 1112-3. [Crossref] [PubMed]
- Angioli R, Penalver M, Muzii L, Mendez L, Mirhashemi R, Bellati F, et al. Guidelines of how to manage vesicovaginal fistula. Crit Rev Oncol Hematol. 2003;48(3): 295-304. [Crossref] [PubMed]
- Enzelsberger H, Gitsch E. Surgical management of vesicovaginal fistulas according to Chassar Moir's method. Surg Gynecol Obstet. 1991;173(3):183-6. [PubMed]
- O'Conor VJ Jr. Review of experience with vesicovaginal fistula repair. J Urol. 1980;123(3):367-9. [Crossref] [PubMed]
- Cetin S, Yazicioğlu A, Ozgür S, Ilker Y, Dalva I. Vesicovaginal fistula repair: a simple suprapubic transvesical approach. Int Urol Nephrol. 1988;20(3):265-8. [Crossref] [PubMed]
- Hadzi-Djokic J, Pejcic TP, Acimovic M. Vesico-vaginal fistula: report of 220 cases. Int Urol Nephrol. 2009; 41(2):299-302. [Crossref] [PubMed]
- Gedik A, Deliktas H, Celik N, Kayan D, Bircan MK. Which surgical technique should be preferred to repair benign, primary vesicovaginal fistulas? Urol J. 2015;12(6):2422-7. [PubMed]
- Zhou L, Yang TX, Luo DY, Chen SL, Liao BH, Li H, et al. Factors influencing repair outcomes of vesicovaginal fistula: A retrospective review of 139 procedures. Urol Int. 2017;99(1):22-8. [Crossref] [PubMed]
- Bodner-Adler B, Hanzal E, Pablik E, Koelbl H, Bodner K. Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: A systematic review and meta-analysis. PLoS One. 2017; 12(2): e0171554. [Crossref] [PubMed] [PMC]
- Raz S, Bregg KJ, Nitti VW, Sussman E. Transvaginal repair of vesicovaginal fistula using a peritoneal flap. J Urol. 1993;150(1):56-9. [Crossref] [PubMed]
- Zimmern PE, Hadley HR, Staskin D, Raz S. Genitourinary fistulas: vaginal approach for repair of vesicovaginal fistulas. Clin Obstet Gynaecol. 1985;12(2): 403-13. [Crossref] [PubMed]
- Moses RA, Ann Gormley E. State of the art for treatment of vesicovaginal fistula. Curr Urol Rep. 2017; 18(8):60. [Crossref] [PubMed]
- Özkaya F, Cinislioğlu AE, Aksoy Y, Adanur Ş, Topdağı Yılmaz EP, Polat Ö, et al. Vesicovaginal fistula repair experiences in a single center high volume of 33 years and necessity of cystostomy. Turk J Urol. 2021;47(1): 66-72. [Crossref] [PubMed] [PMC]
- Yeniyol CÖ, Minareci S, Çiçek S, Değirmenci T, Nergiz N, Ayder AR. Vezikovajinal fistüllerün tedavisinde transvezikal yaklaşım [Transvesical approach in the treatment of vesicovaginal fistulas]. Turk J Urol. 2000;26(2):246-9. [Link]
- Sağnak L, İmamoglu A, Kiper A, Yiğitbaşı O, Ersoy H, Gücük A. Jinekolojik iatrojenik vezikovajinal fistüllerin tedavisinde transvezikal yaklaşım [TransveSical approach in the treatment of gynecologic iatrogenic vesicovaginal fistulas]. Türkiye Klinikleri J Gynecol Obst. 2001;11(5):387-90. [Link]
- Seth J, Kiosoglous A, Pakzad M, Hamid R, Shah J, Ockrim J, Greenwell T. Incidence, type and management of ureteric injury associated with vesicovaginal fistulas: Report of a series from a specialized center. Int J Urol. 2019;26(7):717-23. [Crossref] [PubMed]
.: Process List